Clinical trialNCT03263273CompletedPhase 2Interventional

Study to Evaluate the Safety and Efficacy of Topical Minocycline Gel in Patients With Papulopustular Rosacea

SponsorHovione Scientia LimitedEnrollment270Papulopustular RosaceaRosacea

View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

To evaluate the efficacy of once-daily application of 1% and 3% HY01 Topical Gel, as assessed by the change in inflammatory lesion count from baseline over the 12-week treatment period in patients with moderate-to-severe papulopustular rosacea.

clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Sunil S Dhawan, MD
Center for Dermatology Clinical Research, Inc.
Principal Investigator
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

23 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

Clinical Site - 15
Bryant, Arkansas, United States
Clinical Site - 20
Rogers, Arkansas, United States
Center for Dermatology Clinical Research, Inc.
Fremont, California, United States
Clinical Site - 19
Santa Monica, California, United States
Clinical Site - 5
Tampa, Florida, United States
Clinical Site - 16
Boise, Idaho, United States
Clinical Site - 22
Boston, Massachusetts, United States
Clinical Site - 23
Watertown, Massachusetts, United States
Clinical Site - 14
Clinton Township, Michigan, United States
Clinical Site - 6
Fridley, Minnesota, United States
Clinical Site - 12
Omaha, Nebraska, United States
Clinical Site - 21
Berlin, New Jersey, United States
Clinical Site - 13
New York, New York, United States
Clinical Site - 2
New York, New York, United States
Clinical Site - 4
High Point, North Carolina, United States
Clinical Site - 17
Portland, Oregon, United States
Clinical Site - 11
Fort Washington, Pennsylvania, United States
Clinical Site - 8
Goodlettsville, Tennessee, United States
Clinical Site - 7
Pflugerville, Texas, United States
Clinical Site - 18
San Antonio, Texas, United States
Clinical Site - 3
San Antonio, Texas, United States
Clinical Site - 9
San Antonio, Texas, United States
Clinical Site - 10
Norfolk, Virginia, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

1% Topical Minocycline Gel3% Topical Minocycline Gel

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 30 Oct 2017
Primary completion: 1 Mar 2019
Completion: 1 Jul 2019
Last update posted: 8 Nov 2019
Registered enrollment: 270
Registry id: NCT03263273

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.